Maria Apostolaros currently serves as the Deputy Vice President of Science and Regulatory Advocacy at PhRMA, where she leads regulatory policy priorities, including patient-focused drug development and clinical trial diversity. Prior to PhRMA, Apostolaros worked as a Senior Director of Implementation and Governance at MedImmune/AstraZeneca. She received her JD from the University of Maryland Francis King Carey School of Law, Doctor of Pharmacy from Temple University, and her Masters from Drexel University.
